GermlineBRCAtesting is moving from cancer risk assessment...

Clinical and Translational Oncology 2016 / 10 Vol. 18; Iss. 10

GermlineBRCAtesting is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics

Moreno, L., Linossi, C., Esteban, I., Gadea, N., Carrasco, E., Bonache, S., Gutiérrez-Enríquez, S., Cruz, C., Díez, O., Balmaña, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Clinical and Translational Oncology
DOI:
10.1007/s12094-015-1470-0
Date:
October, 2016
File:
PDF, 504 KB
english, 2016
Conversion to is in progress
Conversion to is failed